As of November 6, 2026, Pharvaris N.V. is a publicly traded company (Nasdaq: PHVS); its largest reported holder is General Atlantic, L.P., with 7.6% on Schedule 13G/A of August 14, 2026, then Viking Global (5.6%) (Schedule 13G/A, August 14, 2026).
Is this your company?
About to sign with, pay or invest in Pharvaris N.V.? See the free Snapshot first.
Free to see. No signup.
Is Pharvaris N.V. a real, registered company?
- Pharvaris N.V. files with the SEC under CIK 1830487 (its SEC filings).
- Its shares are listed under the ticker PHVS on Nasdaq (SEC company record).
- Incorporated in P7, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Pharvaris N.V. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names General Atlantic, L.P. (filed 2026-08-14).
Who are Pharvaris N.V.'s owners and officers?
Pharvaris N.V.: industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-14).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | General Atlantic, L.P. | 7.6% |
| Schedule 13G/A, 2026-07-31 | Lsp V Cooperatieve U.A. | 4.9% |
| Schedule 13G/A, 2026-05-15 | Viking Global Investors LP | 5.6% |
| Schedule 13G/A, 2026-02-17 | Bain Capital Life Sciences Fund, L.P. | 2.5% |
| Schedule 13G/A, 2025-11-14 | Bain Capital Life Sciences Fund, L.P. | 3% |
| Schedule 13G/A, 2025-08-14 | Venrock Healthcare Capital Partners Iii, L.P. | 3.8% |
Questions about who owns Pharvaris N.V.
Who owns Pharvaris N.V.?
On this page, 2 holders' latest ownership filings report 5% or more of Pharvaris N.V.: General Atlantic, L.P. (7.6%, Schedule 13G/A, filed 2026-08-14) and Viking Global Investors LP (5.6%, Schedule 13G/A, filed 2026-05-15).
Who are the largest shareholders of Pharvaris N.V.?
By the share each holder's latest filing reports, the largest holders of Pharvaris N.V. on this page are General Atlantic, L.P. (7.6%) and Viking Global Investors LP (5.6%).
When did General Atlantic, L.P. buy into Pharvaris N.V.?
The filings give report dates, not purchase dates. The earliest filing from General Atlantic, L.P. on this page is the Schedule 13G/A, filed 2026-08-14, reporting 7.6%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 6 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Pharvaris N.V.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Pharvaris N.V.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Pharvaris N.V. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Pharvaris N.V. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and a director: 650,000 shares (1.00% of shares outstanding), held indirectly through By Schoodic Management BV (Form 4, 2026-09-21).
- , the chief early development: 130,419 shares (0.20% of shares outstanding), 56,450 held directly and 73,969 indirectly (Form 4, 2026-09-21).
- , a director: 115,167 shares (0.18% of shares outstanding) (Form 4, 2026-09-24).
- , the chief financial officer and chief legal officer: 113,800 shares (0.17% of shares outstanding) (Form 4, 2026-09-23).
- , the president: 110,035 shares (0.17% of shares outstanding) (Form 4, 2026-10-13).
Shares outstanding: 65,210,590 as of 2025-12-31, from the company's latest SEC cover page.
How much has Pharvaris N.V. raised?
No fundraising or offering filing from Pharvaris N.V. is on file with us.
Keep reading
More on Pharvaris N.V. and the records around it.
Pharvaris N.V. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- Bain Capital Life Sciences Fund, L.P. also filed stake reports on 2 other companies: Rapid Micro Biosystems, Inc. (Aug 2026), X4 PHARMACEUTICALS, INC. (Feb 2026)
- GENERAL ATLANTIC, L.P. also filed stake reports on 10 other companies: Korsana Biosciences, Inc. (Sep 2026), dLocal Ltd (Aug 2026), Liftoff Mobile, Inc. (Jun 2026)
- VIKING GLOBAL INVESTORS LP also filed stake reports on 27 other companies: City Therapeutics, Inc. (Oct 2026), MID AMERICA APARTMENT COMMUNITIES INC. (Oct 2026), REGAL REXNORD CORP (Sep 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/pharvaris-nv